The role of vaccines in preventing bacterial antimicrobial resistance von Jansen, Kathrin U, Knirsch, Charles, Anderson, Annaliesa S

Volltext

A lightspeed approach to pandemic drug development von Anderson, Annaliesa S.

Volltext

Nirmatrelvir–Ritonavir and Viral Load Rebound in Covid-19 von Anderson, Annaliesa S., Caubel, Patrick, Rusnak, James M.

Volltext

The role of vaccines in fighting antimicrobial resistance (AMR) von Jansen, Kathrin U., Anderson, Annaliesa S.

Volltext

Neutralization of BA.4–BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine von Zou, Jing, Kurhade, Chaitanya, Patel, Sohil, Kitchin, Nicholas, Tompkins, Kristin, Cutler, Mark, Cooper, David, Yang, Qi, Cai, Hui, Muik, Alexander, Zhang, Ying, Lee, Dung-Yang, Şahin, Ugur, Anderson, Annaliesa S., Gruber, William C., Xie, Xuping, Swanson, Kena A., Shi, Pei-Yong

Volltext

An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19 von Owen, Dafydd R, Allerton, Charlotte M N, Anderson, Annaliesa S, Aschenbrenner, Lisa, Avery, Melissa, Berritt, Simon, Boras, Britton, Cardin, Rhonda D, Carlo, Anthony, Coffman, Karen J, Dantonio, Alyssa, Li, Di, Eng, Heather, Ferre, RoseAnn, Gajiwala, Ketan S, Gibson, Scott A, Greasley, Samantha E, Hurst, Brett L, Kadar, Eugene P, Kalgutkar, Amit S, Lee, Jack C, Lee, Jisun, Liu, Wei, Mason, Stephen W, Noell, Stephen, Novak, Jonathan J, Obach, R Scott, Ogilvie, Kevin, Patel, Nandini C, Pettersson, Martin, Rai, Devendra K, Reese, Matthew R, Sammons, Matthew F, Sathish, Jean G, Singh, Ravi Shankar P, Steppan, Claire M, Stewart, Al E, Tuttle, Jamison B, Updyke, Lawrence, Verhoest, Patrick R, Wei, Liuqing, Yang, Qingyi, Zhu, Yuao

Volltext

Genetic Surveillance of SARS-CoV-2 Mpro Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid von Lee, Jonathan T., Yang, Qingyi, Gribenko, Alexey, Perrin, B. Scott, Zhu, Yuao, Cardin, Rhonda, Liberator, Paul A., Anderson, Annaliesa S., Hao, Li

Volltext

Innovative Randomized Phase I Study and Dosing Regimen Selection to Accelerate and Inform Pivotal COVID‐19 Trial of Nirmatrelvir von Singh, Ravi Shankar P., Toussi, Sima S., Hackman, Frances, Chan, Phylinda L., Rao, Rohit, Allen, Richard, Van Eyck, Lien, Pawlak, Sylvester, Kadar, Eugene P., Clark, Frances, Shi, Haihong, Anderson, Annaliesa S., Binks, Michael, Menon, Sandeep, Nucci, Gianluca, Bergman, Arthur

Volltext

Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants von Kampmann, Beate, Madhi, Shabir A., Munjal, Iona, Simões, Eric A.F., Pahud, Barbara A., Llapur, Conrado, Baker, Jeffrey, Pérez Marc, Gonzalo, Radley, David, Shittu, Emma, Glanternik, Julia, Snaggs, Hasra, Baber, James, Zachariah, Philip, Barnabas, Shaun L., Fausett, Merlin, Adam, Tyler, Perreras, Nicole, Van Houten, Marlies A., Kantele, Anu, Huang, Li-Min, Bont, Louis J., Otsuki, Takeo, Vargas, Sergio L., Gullam, Joanna, Tapiero, Bruce, Stein, Renato T., Polack, Fernando P., Zar, Heather J., Staerke, Nina B., Duron Padilla, María, Richmond, Peter C., Koury, Kenneth, Schneider, Katherine, Kalinina, Elena V., Cooper, David, Jansen, Kathrin U., Anderson, Annaliesa S., Swanson, Kena A., Gruber, William C., Gurtman, Alejandra

Volltext

Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults von Walsh, Edward E., Pérez Marc, Gonzalo, Zareba, Agnieszka M., Falsey, Ann R., Jiang, Qin, Patton, Michael, Polack, Fernando P., Llapur, Conrado, Doreski, Pablo A., Ilangovan, Kumar, Rämet, Mika, Fukushima, Yasushi, Hussen, Nazreen, Bont, Louis J., Cardona, Jose, DeHaan, Elliot, Castillo Villa, Giselle, Ingilizova, Marinela, Eiras, Daniel, Mikati, Tarek, Shah, Rupal N., Schneider, Katherine, Cooper, David, Koury, Kenneth, Lino, Maria-Maddalena, Anderson, Annaliesa S., Jansen, Kathrin U., Swanson, Kena A., Gurtman, Alejandra, Gruber, William C., Schmoele-Thoma, Beate

Volltext

A Comparative Analysis of SARS-CoV-2 Antivirals Characterizes 3CLpro Inhibitor PF-00835231 as a Potential New Treatment for COVID-19 von de Vries, Maren, Mohamed, Adil S, Prescott, Rachel A, Valero-Jimenez, Ana M, Desvignes, Ludovic, O’Connor, Rebecca, Steppan, Claire, Devlin, Joseph C, Ivanova, Ellie, Herrera, Alberto, Schinlever, Austin, Loose, Paige, Ruggles, Kelly, Koralov, Sergei B, Anderson, Annaliesa S, Binder, Joseph, Dittmann, Meike

Volltext

Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19 von Boras, Britton, Jones, Rhys M., Anson, Brandon J., Arenson, Dan, Aschenbrenner, Lisa, Bakowski, Malina A., Beutler, Nathan, Binder, Joseph, Chen, Emily, Eng, Heather, Hammond, Holly, Hammond, Jennifer, Haupt, Robert E., Hoffman, Robert, Kadar, Eugene P., Kania, Rob, Kimoto, Emi, Kirkpatrick, Melanie G., Lanyon, Lorraine, Lendy, Emma K., Lillis, Jonathan R., Logue, James, Luthra, Suman A., Ma, Chunlong, Mason, Stephen W., McGrath, Marisa E., Noell, Stephen, Obach, R. Scott, O’ Brien, Matthew N., O’Connor, Rebecca, Ogilvie, Kevin, Owen, Dafydd, Pettersson, Martin, Reese, Matthew R., Rogers, Thomas F., Rosales, Romel, Rossulek, Michelle I., Sathish, Jean G., Shirai, Norimitsu, Steppan, Claire, Ticehurst, Martyn, Updyke, Lawrence W., Weston, Stuart, Zhu, Yuao, White, Kris M., García-Sastre, Adolfo, Wang, Jun, Chatterjee, Arnab K., Mesecar, Andrew D., Frieman, Matthew B., Anderson, Annaliesa S., Allerton, Charlotte

Volltext

Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blind... von Absalon, Judith, Segall, Nathan, Block, Stan L, Center, Kimberly J, Scully, Ingrid L, Giardina, Peter C, Peterson, James, Watson, Wendy J, Gruber, William C, Jansen, Kathrin U, Peng, Yahong, Munson, Samantha, Pavliakova, Danka, Scott, Daniel A, Anderson, Annaliesa S

Volltext

The impact of human vaccines on bacterial antimicrobial resistance. A review von Jansen, Kathrin U., Gruber, William C., Simon, Raphael, Wassil, James, Anderson, Annaliesa S.

Volltext

Therapeutics for COVID-19 von Toussi, Sima S., Hammond, Jennifer L., Gerstenberger, Brian S., Anderson, Annaliesa S.

Volltext

Factor H binding protein (FHbp): An evaluation of genotypic diversity across Neisseria meningitidis serogroups von Li, Zhenghui, Murthy, Ashlesh Krishna, Hao, Li, Andrew, Lubomira, Anderson, Annaliesa S

Volltext

A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85 Years von Kitchin, Nicholas, Remich, Shon A, Peterson, James, Peng, Yahong, Gruber, William C, Jansen, Kathrin U, Pride, Michael W, Anderson, Annaliesa S, Knirsch, Charles, Webber, Chris

Volltext

High Resolution Mapping of Bactericidal Monoclonal Antibody Binding Epitopes on Staphylococcus aureus Antigen MntC von Gribenko, Alexey V, Parris, Kevin, Mosyak, Lidia, Li, Sheng, Handke, Luke, Hawkins, Julio C, Severina, Elena, Matsuka, Yury V, Anderson, Annaliesa S

Volltext

Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches von Absalon, Judith, Simon, Raphael, Radley, David, Giardina, Peter C., Koury, Kenneth, Jansen, Kathrin U., Anderson, Annaliesa S.

Volltext

Role of Factor H Binding Protein in Neisseria meningitidis Virulence and Its Potential as a Vaccine Candidate To Broadly Protect against Meningococcal Disease von McNeil, Lisa K, Zagursky, Robert J, Lin, Shuo L, Murphy, Ellen, Zlotnick, Gary W, Hoiseth, Susan K, Jansen, Kathrin U, Anderson, Annaliesa S

Volltext